You're here : Home What is glaucoma?
article thumbnailResearch on SLT

Summary of selected papers on Selective Laser Trabeculoplasty Selective laser trabeculoplasty study: eye drops versus laser - largest...
+ more info

article thumbnailMinimally invasive glaucoma surgery (Xen implant)

Simpler techniques for glaucoma surgery hold increasing promise for patients at risk of progressive disease. These newer micro-invasive...
+ more info

Other Articles
New agents for treating glaucoma: Latanoprostene bunod PDF Print E-mail
Written by Administrator   
Friday, 04 October 2013 10:53

Latanoprostene bunod is a novel compound containing a PG analogue and Nitric Oxide. It appears to offer about 1mmHg further lowering of IOP versus latanoprost, and is a well tolerated medication in early studies; data has been presented at ARVO in 2013. Nitrous oxide has been shown to relax the ciliary muscle and trabecular meshwork, possibly therefore having a combined method of action with enhanced trabecular outflow, and also increased uveoscleral outflow.

Therefore, at this stage, this new medication is likely judged to offer a small but significant advance in treatment, and its release hopefully in the next year or two is anticipated with optimism.

Bunod image

Glaucoma Medications

Last Updated on Monday, 07 October 2013 23:31